A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Olanzapine Based Prophylactic Antiemetic Therapy for Delayed and Persistent Nausea and Vomiting in Patients with HER2-positive or HER2-low Breast Cancer Treated with Trastuzumab Deruxtecan: ERICA Study (WJOG14320B)
ANNALS OF ONCOLOGY（2025）
Key words
trastuzumab deruxtecan,nausea,olanzapine,vomiting,persistent phase
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined